Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA: Philips Healthcare Responded to Warning Letter - Medical Product Outsourcing

FDA: Philips Healthcare Responded to Warning Letter

Firm was not following federal manufacturing standards.

The U.S. Food and Drug Administration (FDA) found during an inspection at Philips Healthcare Inc.’s Andover, Mass., plant that the company was not meeting federal manufacturing standards, and the firm has since met those requirements, according to the federal agency.

The FDA had concluded that Philips, which manufactures medical devices such as patient monitoring cardiac care products and ultrasound transducers, did not use Current Good Manufacturing Practice requirements of the quality system. The agency will conduct a follow-up inspection to assure all changes have been met.

For the complete, warning letter, visit www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm186988.htm.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters